Sector Watch: Healthcare - Sep 25 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $120.23 +0.27 0.23% | XBI: $96.89 +0.23 0.24% | Updated Sep 25, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| AGTC52WH Applied Genetic Technologies $114.2M |
6.30+1.30 1.4 M 10.9x |
26% | ||
| INCR52WH INC Research Holdings $201.0M |
248.90+49.40 5.6 M 3.1x |
25% | ||
| GNCA Genocea Biosciences $62.1M |
0.72+0.11 1.5 M 4.2x |
18% | ||
| EYPT52WH Eyepoint Pharmaceuticals $232.5M |
3.12+0.43 1.8 M 5.4x |
16% | ||
| QHC Quorum Health $173.0M |
5.60+0.76 1.3 M 5.2x |
16% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| TGTX52WL TG Therapeutics $426.5M |
5.15-4.10 12.8 M 10.7x |
-44% | ||
| VSTM Verastem $526.2M |
7.15-1.79 15.1 M 5.3x |
-20% | ||
| NEOG Neogen $3.9B |
74.69-13.99 1.2 M 5.9x |
-16% | ||
| ACRX AcelRx Pharmaceuticals $251.5M |
4.15-0.45 2.3 M 3.7x |
-10% | ||
| CRBP Corbus Pharmaceuticals Holdings $380.4M |
6.65-0.60 1.8 M |
-8% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Verastem Oncology Receives FDA Approval of COPIKTRA? (duvelisib) Capsules | Business Wire [businesswire.com]AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in October [prnewswire.com]
Neogen reports first quarter results [prnewswire.com]
Verastem Oncology Receives FDA Approval of COPIKTRA? (duvelisib) Capsules [businesswire.com]
Proliferative Diabetic Retinopathy (PDR) Review, H2 2018: Pipeline Analysis of 7 Companies & Drug Profiles - ResearchAndMarkets.com | Business Wire [businesswire.com]
Global Uveitis Pipeline Review, H2 2018 - 32 Companies & Drug Pipelines - ResearchAndMarkets.com | Business Wire [businesswire.com]
Genocea to Present at Two October Investor Conferences [globenewswire.com]
AGTC Appoints William Aliski to its Board of Directors Nasdaq:AGTC [globenewswire.com]
Corbus Pharmaceuticals Expands Target Indications by Adding More Than 600 Compounds Focused on the Endocannabinoid System from Jenrin Discovery; Includes CRB-4001 with Planned NIH-Supported Phase 2 Study [globenewswire.com]
Protagonist Therapeutics Reports Granting of Inducement Award [prnewswire.com]
Harpoon Therapeutics Announces Appointments to Board of Directors and Management Team | Business Wire [businesswire.com]
Corbus Pharmaceuticals Receives Orphan Designation for Lenabasum for the Treatment of Dermatomyositis in the European Union [globenewswire.com]
Celsion Appoints Marianne Lambertson as Vice President of Communications and Investor Relations [globenewswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
